Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,308.00
0.00 (0.00%)
At close: Aug 14, 2026
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 239.22 billion as of August 14, 2026. Its market cap has decreased by -37.12% in one year.
Market Cap
239.22B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
24.45
Stock Price
1,308.00
ChartMarket Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 239.22B, an increase of 287.07%. That is a compound annual growth rate of 4.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 239.22B | -34.60% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Huons | 304.11B |
| JW Holdings | 286.10B |
| Humedix | 282.77B |
| Suheung | 276.73B |
| Korea United Pharm | 262.36B |
| Boditech Med | 229.90B |
| Samjin Pharmaceuticals | 226.03B |
| Chong Kun Dang Holdings | 195.18B |